Spots Global Cancer Trial Database for uterine cervix
Every month we try and update this database with for uterine cervix cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age | NCT03177863 | CIN2 Therapy | Expectancy | 25 Years - 30 Years | Sahlgrenska University Hospital, Sweden | |
Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix | NCT02346227 | Uterine Cervica... Papillomavirus ... | AV2 Placebo | 25 Years - | Universiteit Antwerpen | |
A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA) | NCT02363829 | Uterine Cervix ... | Nelfinavir Cisplatin | 18 Years - | Abramson Cancer Center at Penn Medicine | |
How to Avoid Cervical Stenosis After LEEP in High Grade Cervical Dysplasia? | NCT02500966 | Stenosis Cervix | DUDA device LEEP | 18 Years - 65 Years | Barretos Cancer Hospital | |
Laparoscopic Approach to Cervical Cancer | NCT00614211 | Cervical Cancer | Total Abdominal... Total Laparosco... | 18 Years - | Queensland Centre for Gynaecological Cancer | |
Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age | NCT03177863 | CIN2 Therapy | Expectancy | 25 Years - 30 Years | Sahlgrenska University Hospital, Sweden | |
A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA) | NCT02363829 | Uterine Cervix ... | Nelfinavir Cisplatin | 18 Years - | Abramson Cancer Center at Penn Medicine |